Endo Stock News

Endo (ENDP) tops Q4 earnings and sales estimates. However, Vasostrict faces generic competition, and the ongoing COVID-19 driven market conditions affect specialty product office-based procedures.

Endo International (ENDP) shares are down 6% in after-hours trading despite reporting Q4 2021 earnings results that beat on the top and bottom lines.

DUBLIN , Feb. 28, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and introduced first-quarter 2022 financial guidance. "Endo''s solid operational and financial performance in the

In the latest trading session, 0.71 million Endo International plc (NASDAQ:ENDP) shares changed hands as the company’s beta touched 1.11. With the company’s most recent per share price at $3.22 changed hands at -$0.03 or -0.92% at last look, the market valuation stands at $721.99M. ENDP’s current price is a discount, trading about -183.85% off … Endo International plc (ENDP): Why Is Stock So Good? Read More »

Endo's (ENDP) fourth-quarter earnings might have gained from higher sales of Xiaflex.

FORT LAUDERDALE, Fla. , Feb. 15, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE: CNVY ) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board"). Mr. Campanelli has approximately 30 years of experience in the healthcare industry, including leadership positions in both publicly held and private equity controlled companies. Mr. Campanelli previously served as Chairman of the Board of Endo International ("Endo") from November 2019 to June 2021 , and previously served as President and Chief Executive Officer of Endo from September 2016 to March 2020 . While acting as Chief Executive Officer, Mr. Campanelli focused on executing Endo''s strategy to improve productivity, simplify its business, and increase the value of the company''s US Branded, US Generics and international pharmaceutical assets. Prior to joining Endo, Mr. Campanelli served … Full story available on Benzinga.com

Miller Value Partners, an investment management firm, published its Miller Deep Value Strategy fourth quarter 2021 investor letter a copy of which can be seen here.

DUBLIN ,, Feb. 11, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it expects a Tennessee state court to issue an order granting plaintiffs'' request for a default judgment on liability against Endo''s wholly-owned subsidiaries Endo Health Solutions Inc. and Endo

Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

In the latest trading session, Endo International (ENDP) closed at $3.14, marking a +1.95% move from the previous day.

Endo International (ENDP) closed at $3.21 in the latest trading session, marking a +0.63% move from the prior day.

Is Endo International (ENDP) a great pick from the value investor's perspective right now? Read on to know more.

DUBLIN, Jan. 25, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth–quarter and full-year 2021 financial results on February 28, 2022 and members of its senior mana

(Reuters) – Drugmaker Endo International plc said on Tuesday it had agreed to pay up to $65 million to resolve claims by the state of Florida and local governments that the drugmaker helped fuel the U.S. opioid epidemic.